Raymond James Downgrades Ginkgo Bioworks Holdings to Market Perform, Announces $2.5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Rahul Sarugaser has downgraded Ginkgo Bioworks Holdings (NYSE:DNA) from Outperform to Market Perform and set a price target of $2.5.
November 15, 2023 | 4:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ginkgo Bioworks Holdings was downgraded by Raymond James from Outperform to Market Perform with a price target of $2.5.
Downgrades by analysts can lead to negative investor sentiment and potential short-term price declines. The new price target of $2.5 suggests a limited upside or even a downside if the stock was trading above this level prior to the downgrade.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100